Physician profile

Weekon Choi

Pulmonary Disease · Englewood Cliffs, NJ

NPI 1609806694

$1,987.83

in general payments reported to CMS, 2019-2025

18 companies · $344 in 2025

The $344 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$876.10

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Glaxosmithkline, LLC. $645.31 2021-2025 Nucala, Trelegy Ellipta
Boehringer Ingelheim Pharmaceuticals, INC. $255.37 2019-2025 Jascayd, Ofev
Harmony Biosciences LLC $210.39 2022-2025 Wakix
Jazz Pharmaceuticals INC. $161.30 2019-2022
Insmed, INC. $131.42 2020-2024 Arikayce
Astrazeneca Pharmaceuticals LP $128.16 2019-2022
Amgen INC. $115.92 2022
United Therapeutics Corporation $77.70 2022-2025 Tyvaso, Tyvaso
Aerin Medical INC. $54.87 2025
Inogen, INC. $37.32 2025
Avadel Cns Pharmaceuticals, LLC $35.21 2025 Lumryz
Medtronic, INC. $26.19 2021
Baxter Healthcare $23.49 2022
Philips North America LLC $20.00 2023
Pulmonx Corporation $18.95 2025 Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter
Show all 18 companies
CompanyGeneral paymentsYearsTop products
Inspire Medical Systems, INC. $17.06 2024 Inspire
Axsome Therapeutics, INC. $16.61 2023 Sunosi
Mallinckrodt Hospital Products INC. $12.56 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Weekon Choi

$1,987.83

in general payments reported 2019-2025

Years
2019-2025
Top company
Glaxosmithkline, LLC.
Context
The $344 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).

https://glasscript.com/doctor/117630/weekon-choi

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.